Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry

ALK-Rearranged Adenosquamous Lung Cancer Presenting as Squamous Cell Carcinoma: A Potential Challenge to Histologic Type Triaging of NSCLC Biopsies for Molecular Studies

(2014) Konstantin H. Dragnev et al.   Clinical Lung Cancer

Long-Term Response to Gefitinib and Crizotinib in Lung Adenocarcinoma Harboring Both Epidermal Growth Factor Receptor Mutation andEML4-ALKFusion Gene

(2014) Rita Chiari et al.   JOURNAL OF CLINICAL ONCOLOGY

Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas

(2014) Dongsheng Yue et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Relationship Between EGFR Expression, EGFR Mutation Status, and the Efficacy of Chemotherapy Plus Cetuximab in FLEX Study Patients with Advanced Non–Small-Cell Lung Cancer

(2014) Jean-Yves Douillard et al.   Journal of Thoracic Oncology

Smoky coal, tobacco smoking, and lung cancer risk in Xuanwei, China

(2014) Christopher Kim et al.   LUNG CANCER

Lung Cancer in China

(2013) Jun She et al.   CHEST

Analysis ofEGFR,EML4-ALK,KRAS, andc-METmutations in Chinese lung adenocarcinoma patients

(2013) Ning Xia et al.   EXPERIMENTAL LUNG RESEARCH

Inflammatory myofibroblastic tumour of the lung with a novelPPFIBP1-ALKfusion variant

(2013) Akihiko Yoshida et al.   HISTOPATHOLOGY

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant

(2013) Ka-Fai To et al.   Journal of Thoracic Oncology

Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK-Rearranged Lung Adenocarcinomas

(2013) Lynette M. Sholl et al.   Journal of Thoracic Oncology

Large-Scale Screening and Molecular Characterization of EML4-ALK Fusion Variants in Archival Non–Small-Cell Lung Cancer Tumor Specimens Using Quantitative Reverse Transcription Polymerase Chain Reaction Assays

(2013) Tianhong Li et al.   Journal of Thoracic Oncology

Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)

(2013) Ole Raaschou-Nielsen et al.   LANCET ONCOLOGY

A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations

(2013) Doraid Alrifai et al.   LUNG CANCER

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization

(2013) Christina I Selinger et al.   MODERN PATHOLOGY

Comparison of IHC, FISH and RT-PCR Methods for Detection of ALK Rearrangements in 312 Non-Small Cell Lung Cancer Patients in Taiwan

(2013) Yi-Cheng Wu et al.   PLoS One

Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas

(2012) Claudia Abbruzzese et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib

(2012) Oana Pop et al.   Journal of Thoracic Oncology

Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene

(2012) Takayuki Fukui et al.   LUNG CANCER

Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?

(2012) Nobuaki Ochi et al.   LUNG CANCER

Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer

(2012) N Sunaga et al.   ONCOGENE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

An E3 ubiquitin ligase: c-Cbl

(2011) Fang-Yi Lo et al.   CANCER

Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease?

(2011) Sabina Antonela Antoniu   EXPERT OPINION ON THERAPEUTIC TARGETS

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR

(2011) Shang-Gin Wu et al.   Journal of Thoracic Oncology

Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK

(2011) R. Katayama et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epithelioid Inflammatory Myofibroblastic Sarcoma

(2010) Adrián Mariño-Enríquez et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma

(2010) W. Waggott et al.   BRITISH JOURNAL OF HAEMATOLOGY

Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma

(2010) R. Jokoji et al.   JOURNAL OF CLINICAL PATHOLOGY

ALK Gene Rearrangements: A New Therapeutic Target in a Molecularly Defined Subset of Non-small Cell Lung Cancer

(2010) Benjamin Solomon et al.   Journal of Thoracic Oncology

Oncogenic mutation of PIK3CA in small cell lung carcinoma: A potential therapeutic target pathway for chemotherapy-resistant lung cancer

(2009) Tatsuhiro Shibata et al.   CANCER LETTERS